← Back to patent-cliff list
YH-12852
Tier C — Watch / tradeYH-12852
Yuhan Corporation
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：5-HT4
Indications (approved)：Gastroparesis, Dyspepsia, Constipation
Regional status
US
Phase II
2022-03-09
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of YH-12852?
Approved indications include: Gastroparesis, Dyspepsia, Constipation.
When does the YH-12852 patent expire?
No public expiry year is available for YH-12852 yet; this page updates once verified.
How do I get a quote for YH-12852 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-11